• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PROMIS-29 和 EORTC QLQ-C30:对健康统一概念的实证研究。

PROMIS-29 and EORTC QLQ-C30: an empirical investigation towards a common conception of health.

机构信息

Department of Psychosomatic Medicine, Center of Internal Medicine and Dermatology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.

Department of Gynecology With Breast Center, Charité University Hospital Berlin, Berlin, Germany.

出版信息

Qual Life Res. 2023 Mar;32(3):749-758. doi: 10.1007/s11136-022-03324-7. Epub 2023 Jan 9.

DOI:10.1007/s11136-022-03324-7
PMID:36617606
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9992045/
Abstract

PURPOSE

The assessment of health-related quality of life (HRQOL) measured via patient-reported outcomes (PROs) is a key component in clinical trials and increasingly used in clinical routine worldwide. Two PRO measures (PROMs) that share the same definition of health and report outcomes on a comparable T-metric anchored to general population samples are the PROMIS-29 and the EORTC QLQ-C30. In this study, we investigate the empirical agreement of these underlying concepts.

METHODS

We collected PROMIS-29 and EORTC QLQ-C30 data from 1,478 female patients at a breast cancer outpatient centre. We calculated descriptive statistics and correlations between the subscales of both instruments. We performed exploratory (EFA) and confirmatory factor analysis (CFA) in randomly split subsamples in order to assess the underlying psychometric structure of both instruments.

RESULTS

The cohort (mean age = 47.4, ± 14.49) reported comparable mean HRQOL scores between the corresponding subscales of both instruments similar to general population reference values. Correlation between the corresponding subscales of both instruments ranged between 0.59 (Social Role) and 0.78 (Physical Functioning). Both an exploratory and a theoretically driven confirmatory factor analysis provided further support for conceptual agreement of the scales.

CONCLUSION

EORTC QLQ-C30 and PROMIS-29 showed similar scores and satisfactory agreement in conceptional and statistical analysis. This suggests that the underlying conceptualization of health is reasonably close. Hence, the development of score transformation algorithms or calibration of both instruments on common scales could prospectively increase the comparability of clinical and research PRO data collected with either instrument.

摘要

目的

通过患者报告的结果(PROs)评估健康相关生活质量(HRQOL)是临床试验的关键组成部分,并且在全球范围内越来越多地用于临床常规。两种具有相同健康定义并在可比的 T 度量上报告结果的 PRO 测量工具(PROMs),即 PROMIS-29 和 EORTC QLQ-C30。在这项研究中,我们研究了这些基本概念的经验一致性。

方法

我们从一家乳腺癌门诊中心收集了 1478 名女性患者的 PROMIS-29 和 EORTC QLQ-C30 数据。我们计算了两个工具的子量表之间的描述性统计和相关性。我们在随机分割的子样本中进行了探索性(EFA)和验证性因素分析(CFA),以评估两个工具的潜在心理计量结构。

结果

该队列(平均年龄 47.4±14.49)报告了两个工具的相应子量表之间的可比平均 HRQOL 评分,类似于一般人群的参考值。两个工具的相应子量表之间的相关性在 0.59(社会角色)和 0.78(身体功能)之间。探索性和理论驱动的验证性因素分析都为量表的概念一致性提供了进一步的支持。

结论

EORTC QLQ-C30 和 PROMIS-29 在概念和统计学分析方面表现出相似的评分和令人满意的一致性。这表明健康的基本概念是相当接近的。因此,开发评分转换算法或在共同量表上校准两个工具,有望提高使用任一工具收集的临床和研究 PRO 数据的可比性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f014/9992045/69be897c4e7a/11136_2022_3324_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f014/9992045/69be897c4e7a/11136_2022_3324_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f014/9992045/69be897c4e7a/11136_2022_3324_Fig1_HTML.jpg

相似文献

1
PROMIS-29 and EORTC QLQ-C30: an empirical investigation towards a common conception of health.PROMIS-29 和 EORTC QLQ-C30:对健康统一概念的实证研究。
Qual Life Res. 2023 Mar;32(3):749-758. doi: 10.1007/s11136-022-03324-7. Epub 2023 Jan 9.
2
Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.两种癌症患者生活质量评估工具的比较:癌症治疗功能评估通用版与欧洲癌症研究与治疗组织生活质量问卷-C30。
J Clin Oncol. 1999 Sep;17(9):2932-40. doi: 10.1200/JCO.1999.17.9.2932.
3
Psychometric properties of the EORTC QLQ-C30 in Uganda.《EORTC QLQ-C30 在乌干达的心理测量特性》。
Health Qual Life Outcomes. 2021 Apr 23;19(1):131. doi: 10.1186/s12955-021-01769-x.
4
Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial.欧洲癌症研究与治疗组织核心问卷(EORTC QLQ-C30)电子患者报告结局(e-PRO)工具用于测量乳腺癌患者健康相关生活质量的可靠性:前瞻性随机试验
J Med Internet Res. 2017 Sep 14;19(9):e322. doi: 10.2196/jmir.8210.
5
General population normative values for the EORTC QLQ-C30 by age, sex, and health condition for the French general population.一般人群 EORTC QLQ-C30 量表的常模值,按年龄、性别和健康状况分组,针对法国一般人群。
J Patient Rep Outcomes. 2024 May 2;8(1):48. doi: 10.1186/s41687-024-00719-7.
6
EORTC QLQ-C30 general population normative data for Italy by sex, age and health condition: an analysis of 1,036 individuals.EORTC QLQ-C30 普通人群意大利人群的性别、年龄和健康状况的常模数据:对 1036 个人的分析。
BMC Public Health. 2022 May 24;22(1):1040. doi: 10.1186/s12889-022-13211-y.
7
Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review.规范局部前列腺癌患者报告结局测量的评估。系统评价。
Eur Urol Oncol. 2022 Apr;5(2):153-163. doi: 10.1016/j.euo.2021.10.004. Epub 2021 Nov 14.
8
Health-Related Quality of Life among Women Breast Cancer Patients in Eastern China.中国东部女性乳腺癌患者的健康相关生活质量。
Biomed Res Int. 2018 Jul 3;2018:1452635. doi: 10.1155/2018/1452635. eCollection 2018.
9
Patient-reported outcome measures for emotional functioning in cancer patients: Content comparison of the EORTC CAT Core, FACT-G, HADS, SF-36, PRO-CTCAE, and PROMIS instruments.癌症患者情绪功能的患者报告结局指标:欧洲癌症研究与治疗组织核心癌症治疗功能评估量表(EORTC CAT Core)、癌症治疗功能评价系统通用量表(FACT-G)、医院焦虑抑郁量表(HADS)、健康调查简表(SF-36)、癌症治疗相关不良事件患者报告结局量表(PRO-CTCAE)及患者报告结果测量信息系统(PROMIS)工具的内容比较
Psychooncology. 2023 Apr;32(4):628-639. doi: 10.1002/pon.6109. Epub 2023 Feb 19.
10
Cardiovascular health-related quality of life in cancer: a prospective study comparing the ESC HeartQoL and EORTC QLQ-C30 questionnaire.癌症患者的心血管健康相关生活质量:一项比较 ESC HeartQoL 和 EORTC QLQ-C30 问卷的前瞻性研究。
Eur J Heart Fail. 2023 Sep;25(9):1635-1647. doi: 10.1002/ejhf.2951. Epub 2023 Aug 22.

引用本文的文献

1
Supportive care needs and quality of life among cancer patients in China: A cross-sectional study.中国癌症患者的支持性护理需求与生活质量:一项横断面研究。
PLoS One. 2025 Aug 28;20(8):e0331149. doi: 10.1371/journal.pone.0331149. eCollection 2025.
2
Assessing Quality of Life and Symptoms in Transplantation and CAR-T Recipients: Expert Panel Recommendations from the Survivorship Special Interest Group of ASTCT.评估移植和CAR-T治疗受者的生活质量及症状:美国血液和骨髓移植学会(ASTCT)生存特别兴趣小组的专家小组建议
Transplant Cell Ther. 2025 Jul 1. doi: 10.1016/j.jtct.2025.06.030.
3
Pilot Randomized Controlled Trial of iCanWork: Theory-Guided Return-to-Work Intervention for Individuals Touched by Cancer.

本文引用的文献

1
Common measures or common metrics? A plea to harmonize measurement results.常用指标还是通用指标?呼吁协调测量结果
Clin Psychol Psychother. 2022 Sep;29(5):1755-1767. doi: 10.1002/cpp.2742. Epub 2022 Jun 19.
2
PROMIS Adult Health Profiles: Efficient Short-Form Measures of Seven Health Domains.PROMIS 成人健康概况量表:七个健康领域的高效简明测量工具。
Value Health. 2019 May;22(5):537-544. doi: 10.1016/j.jval.2019.02.004.
3
Assessment of change in quality of life, carcinoid syndrome symptoms and healthcare resource utilization in patients with carcinoid syndrome.
iCanWork的试点随机对照试验:针对受癌症影响个体的理论指导重返工作干预
Curr Oncol. 2025 May 1;32(5):266. doi: 10.3390/curroncol32050266.
4
Lower extremity lymphedema in patients with gynecologic cancer: Validation of the Gynecologic Cancer Lymphedema Questionnaire (GCLQ) in German language and investigation of lymphedema real-world treatment.妇科癌症患者的下肢淋巴水肿:德语版妇科癌症淋巴水肿问卷(GCLQ)的验证及淋巴水肿实际治疗情况调查
Arch Gynecol Obstet. 2025 Apr;311(4):1151-1162. doi: 10.1007/s00404-024-07886-4. Epub 2024 Dec 23.
5
Variability of quality-of-life measurements and reporting in randomised controlled trials of pancreatic cancer: a systematic review.胰腺癌随机对照试验中生活质量测量和报告的变异性:系统评价。
BMJ Open. 2024 Nov 17;14(11):e083696. doi: 10.1136/bmjopen-2023-083696.
评估类癌综合征患者生活质量的变化、类癌综合征症状和医疗资源利用情况。
BMC Cancer. 2019 Mar 28;19(1):274. doi: 10.1186/s12885-019-5459-x.
4
Pilot Study of an Internet-Based Self-Management Program for Symptom Control in Patients With Early-Stage Breast Cancer.基于互联网的早期乳腺癌患者症状控制自我管理项目的初步研究。
JCO Clin Cancer Inform. 2018 Dec;2:1-12. doi: 10.1200/CCI.17.00106.
5
Establishing the European Norm for the health-related quality of life domains of the computer-adaptive test EORTC CAT Core.建立与健康相关的生活质量领域的欧洲规范,适应测试 EORTC CAT 核心。
Eur J Cancer. 2019 Jan;107:133-141. doi: 10.1016/j.ejca.2018.11.023. Epub 2018 Dec 18.
6
PROMIS-29 v2.0 profile physical and mental health summary scores.PROMIS-29 v2.0 概况身心健康综合评分。
Qual Life Res. 2018 Jul;27(7):1885-1891. doi: 10.1007/s11136-018-1842-3. Epub 2018 Mar 22.
7
Measurement invariance and general population reference values of the PROMIS Profile 29 in the UK, France, and Germany.PROMIS Profile 29 在英国、法国和德国的测量不变性和一般人群参考值。
Qual Life Res. 2018 Apr;27(4):999-1014. doi: 10.1007/s11136-018-1785-8. Epub 2018 Jan 19.
8
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment.一项评估常规癌症治疗期间症状监测的患者报告结局的试验的总生存结果。
JAMA. 2017 Jul 11;318(2):197-198. doi: 10.1001/jama.2017.7156.
9
Health-related quality of life in patients with neuroendocrine tumors: an investigation of treatment type, disease status, and symptom burden.神经内分泌肿瘤患者的健康相关生活质量:治疗类型、疾病状态及症状负担的调查
Support Care Cancer. 2016 Sep;24(9):3695-703. doi: 10.1007/s00520-016-3189-z. Epub 2016 Mar 31.
10
Deriving a preference-based utility measure for cancer patients from the European Organisation for the Research and Treatment of Cancer's Quality of Life Questionnaire C30: a confirmatory versus exploratory approach.从欧洲癌症研究与治疗组织的生活质量问卷C30中推导基于偏好的癌症患者效用度量:验证性方法与探索性方法
Patient Relat Outcome Meas. 2014 Nov 6;5:119-29. doi: 10.2147/PROM.S68776. eCollection 2014.